Research articlePublished 2016

PET - CT Scan Shows Decreased Severity of Autism after Autologous Cellular Therapy: A Case Report

Authors: Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Prerna Badhe, Avantika Patil, Pooja Kulkarni, Amruta Paranjape

Autism-Open Access

Volume 6 · Issue 2 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

PET - CT scan has been recently utilized to detect functional abnormalities in the brain. In autism, the MRI of brain is normal hence, functional neuroimaging techniques such as Positron Emission Tomography - Computer Tomography scan of the brain should be explored. Autism is a complex neurodevelopmental disorder affecting communication, behavior and socialization. Currently, available therapeutic approaches are aimed at symptomatic changes and do not target the core pathology in the brain of autism. Cell therapy has recently emerged as a promising treatment modality for autism. However, the effects of cell therapy need to be monitored by objective imaging. In this study, we present the case of a 6 year old boy with autism treated with intrathecal administration of autologous bone marrow mononuclear cells and monitored with Positron Emission Tomography - Computer Tomography scan. On regular follow up at 3 and 6 months, significant social, behavioral and communication improvements were observed. On outcome measures, the Indian Scale for Assessment of Autism score pre - intervention improved from 113 to 97, Functional Independence Measure improved significantly from 42 to 50 and Childhood Autism Rating Scale improved from 42.5 to 35.5. The severity of illness on Clinical Global Impression scale showed a change from a score of 5 (markedly ill) to 4 (moderately ill). Global improvement graded on the CGI scale was 2 (much improved). The efficacy index on Childhood Autism Rating Scale showed moderate therapeutic effect (score 5). Interestingly, Positron Emission Tomography - Computer Tomography comparisons at 6 months revealed improved metabolism of the previously hypometabolic areas of the brain which correlated well with clinical improvements. No adverse events were reported.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

More from this journal

The newest in Autism-Open Access.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAutism-Open Access
  • SubjectMental Health and Psychology
  • BylineArticles whose byline prints “Alok Sharma”
  • BylineArticles whose byline prints “Hemangi Sane”
  • BylineArticles whose byline prints “Nandini Gokulchandran”
  • BylineArticles whose byline prints “Prerna Badhe”
  • BylineArticles whose byline prints “Avantika Patil”
  • BylineArticles whose byline prints “Pooja Kulkarni”
  • BylineArticles whose byline prints “Amruta Paranjape”